Logo image of ITI

Iteris Incorporated New (ITI) Stock Fundamental Analysis

NASDAQ:ITI - Nasdaq - US46564T1079 - Common Stock - Currency: USD

7.19  -0.01 (-0.14%)

Premarket: 7.19 0 (0%)

Fundamental Rating

5

ITI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. ITI has only an average score on both its financial health and profitability. ITI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ITI was profitable.
ITI had a positive operating cash flow in the past year.
In multiple years ITI reported negative net income over the last 5 years.
In multiple years ITI reported negative operating cash flow during the last 5 years.
ITI Yearly Net Income VS EBIT VS OCF VS FCFITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

ITI has a Return On Assets (1.12%) which is in line with its industry peers.
ITI has a Return On Equity (1.99%) which is comparable to the rest of the industry.
ITI's Return On Invested Capital of 1.26% is in line compared to the rest of the industry. ITI outperforms 53.23% of its industry peers.
Industry RankSector Rank
ROA 1.12%
ROE 1.99%
ROIC 1.26%
ROA(3y)-5.51%
ROA(5y)-2.81%
ROE(3y)-9.55%
ROE(5y)-4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ITI Yearly ROA, ROE, ROICITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ITI has a Profit Margin of 0.80%. This is comparable to the rest of the industry: ITI outperforms 53.23% of its industry peers.
In the last couple of years the Profit Margin of ITI has declined.
ITI has a Operating Margin (0.64%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ITI has grown nicely.
ITI has a Gross Margin of 37.38%. This is in the better half of the industry: ITI outperforms 63.71% of its industry peers.
In the last couple of years the Gross Margin of ITI has remained more or less at the same level.
Industry RankSector Rank
OM 0.64%
PM (TTM) 0.8%
GM 37.38%
OM growth 3Y11.09%
OM growth 5YN/A
PM growth 3Y-40.46%
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5Y-0.15%
ITI Yearly Profit, Operating, Gross MarginsITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ITI is destroying value.
ITI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ITI has more shares outstanding
There is no outstanding debt for ITI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ITI Yearly Shares OutstandingITI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ITI Yearly Total Debt VS Total AssetsITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.69 indicates that ITI is not in any danger for bankruptcy at the moment.
ITI's Altman-Z score of 3.69 is fine compared to the rest of the industry. ITI outperforms 62.10% of its industry peers.
There is no outstanding debt for ITI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.69
ROIC/WACC0.13
WACC9.39%
ITI Yearly LT Debt VS Equity VS FCFITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ITI has a Current Ratio of 1.77. This is a normal value and indicates that ITI is financially healthy and should not expect problems in meeting its short term obligations.
ITI has a Current ratio of 1.77. This is in the lower half of the industry: ITI underperforms 70.16% of its industry peers.
ITI has a Quick Ratio of 1.44. This is a normal value and indicates that ITI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ITI (1.44) is worse than 62.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.44
ITI Yearly Current Assets VS Current LiabilitesITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 116.67% over the past year.
Measured over the past years, ITI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -34.58% on average per year.
Looking at the last year, ITI shows a small growth in Revenue. The Revenue has grown by 4.99% in the last year.
ITI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.01% yearly.
EPS 1Y (TTM)116.67%
EPS 3Y-34.58%
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)4.99%
Revenue growth 3Y13.67%
Revenue growth 5Y13.01%
Sales Q2Q%5.13%

3.2 Future

The Earnings Per Share is expected to grow by 101.85% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.26% on average over the next years. This is quite good.
EPS Next Y159.71%
EPS Next 2Y118.21%
EPS Next 3Y101.85%
EPS Next 5YN/A
Revenue Next Year10.08%
Revenue Next 2Y11.82%
Revenue Next 3Y12.26%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ITI Yearly Revenue VS EstimatesITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
ITI Yearly EPS VS EstimatesITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 239.67 indicates a quite expensive valuation of ITI.
ITI's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.99, ITI is valued quite expensively.
ITI is valuated rather expensively with a Price/Forward Earnings ratio of 21.57.
ITI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ITI is cheaper than 70.16% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 96.58. ITI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 239.67
Fwd PE 21.57
ITI Price Earnings VS Forward Price EarningsITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ITI.
ITI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 235.51
EV/EBITDA 55.92
ITI Per share dataITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

ITI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ITI's earnings are expected to grow with 101.85% in the coming years.
PEG (NY)1.5
PEG (5Y)N/A
EPS Next 2Y118.21%
EPS Next 3Y101.85%

0

5. Dividend

5.1 Amount

No dividends for ITI!.
Industry RankSector Rank
Dividend Yield N/A

Iteris Incorporated New

NASDAQ:ITI (10/31/2024, 8:13:36 PM)

Premarket: 7.19 0 (0%)

7.19

-0.01 (-0.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners69.2%
Inst Owner Change-30.84%
Ins Owners3.66%
Ins Owner Change-51.25%
Market Cap309.46M
Analysts46.67
Price Target7.34 (2.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-89.39%
Min EPS beat(2)-100%
Max EPS beat(2)-78.79%
EPS beat(4)1
Avg EPS beat(4)-47.55%
Min EPS beat(4)-100%
Max EPS beat(4)32.01%
EPS beat(8)3
Avg EPS beat(8)4.7%
EPS beat(12)3
Avg EPS beat(12)-309.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.05%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)2.58%
Revenue beat(4)2
Avg Revenue beat(4)1.48%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)3.89%
Revenue beat(8)6
Avg Revenue beat(8)4.6%
Revenue beat(12)6
Avg Revenue beat(12)2.15%
Revenue beat(16)8
Avg Revenue beat(16)1.61%
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)12.49%
EPS NQ rev (3m)-47.06%
EPS NY rev (1m)1.88%
EPS NY rev (3m)-38.64%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)-2.19%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 239.67
Fwd PE 21.57
P/S 1.78
P/FCF 235.51
P/OCF 83.41
P/B 4.4
P/tB 9.33
EV/EBITDA 55.92
EPS(TTM)0.03
EY0.42%
EPS(NY)0.33
Fwd EY4.64%
FCF(TTM)0.03
FCFY0.42%
OCF(TTM)0.09
OCFY1.2%
SpS4.05
BVpS1.63
TBVpS0.77
PEG (NY)1.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 1.99%
ROCE 1.39%
ROIC 1.26%
ROICexc 1.71%
ROICexgc 4.57%
OM 0.64%
PM (TTM) 0.8%
GM 37.38%
FCFM 0.75%
ROA(3y)-5.51%
ROA(5y)-2.81%
ROE(3y)-9.55%
ROE(5y)-4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y41.57%
ROICexcg growth 5YN/A
ROICexc growth 3Y34.52%
ROICexc growth 5YN/A
OM growth 3Y11.09%
OM growth 5YN/A
PM growth 3Y-40.46%
PM growth 5YN/A
GM growth 3Y-2.12%
GM growth 5Y-0.15%
F-Score8
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 59.44%
Cap/Sales 1.38%
Interest Coverage 250
Cash Conversion 72.01%
Profit Quality 94.06%
Current Ratio 1.77
Quick Ratio 1.44
Altman-Z 3.69
F-Score8
WACC9.39%
ROIC/WACC0.13
Cap/Depr(3y)59.96%
Cap/Depr(5y)55.27%
Cap/Sales(3y)1.51%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.67%
EPS 3Y-34.58%
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y159.71%
EPS Next 2Y118.21%
EPS Next 3Y101.85%
EPS Next 5YN/A
Revenue 1Y (TTM)4.99%
Revenue growth 3Y13.67%
Revenue growth 5Y13.01%
Sales Q2Q%5.13%
Revenue Next Year10.08%
Revenue Next 2Y11.82%
Revenue Next 3Y12.26%
Revenue Next 5YN/A
EBIT growth 1Y114.75%
EBIT growth 3Y26.28%
EBIT growth 5YN/A
EBIT Next Year275.63%
EBIT Next 3Y96.04%
EBIT Next 5YN/A
FCF growth 1Y108.39%
FCF growth 3Y17.68%
FCF growth 5YN/A
OCF growth 1Y126.16%
OCF growth 3Y20.58%
OCF growth 5YN/A